CG Oncology paid its 7 named executives $25.8M in total in FY2025 (Dec). CEO Arthur Kuan was paid $11.9M of that.
Pay$100 in the stock at the end of FY24 → $145
Pay of each named executive
Arthur KuanChief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
Ambaw BelletePresident and Chief Operating Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
Vijay KasturiChief Medical Officer
| FY2025 (Dec) |
1 year
Joshua F. PattersonGeneral Counsel, Chief Compliance Officer, and Secretary
| FY2025 (Dec) |
1 year
Corleen RochePrior Chief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
Robert Lapetina (PriorInterim Principal Financial and Accounting Officer)
| FY2025 (Dec) |
1 year
Jim DeToreChief Financial Officer
| FY2025 (Dec) |
1 year
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.